BioCentury | Jan 11, 2021
Deals

Atopic dermatitis readout drives Sanofi’s $1.1B takeout of Kymab

...Bill & Melinda Gates Foundation and Malin Corp. plc (ISE:MLC) were also shareholders. Funds associated with Woodford Investment Management...
BioCentury | Jun 6, 2020
Finance

Sale of up to 19 Woodford stakes chips away at firm’s remaining portfolio

...unable to meet redemption requests. Subsequent attempts to rebalance the fund failed, and Woodford shuttered Woodford Investment Management...
...years, Woodford participated in some of U.K. biotech’s largest deals. According to BioCentury’s BCIQ database, Woodford Investment Management...
...complete. BlackRock and PJT will continue to seek buyers for the remaining assets. Stephen Hansen, Associate Editor Woodford Investment Management U.K...
BioCentury | Mar 2, 2020
Finance

Immunocore’s $130M series B gives new CEO Jallal capital to progress pipeline

...leadership team. More turmoil followed when one of Immunocore’s largest investors from the series A, Woodford Investment Management...
BioCentury | Feb 10, 2020
Finance

Woodford pain continues as report suggests deal to sell private biotech stakes falls through

...fund. PJT Partners, which is managing the asset sale, declined to comment. Woodford shuttered the Woodford Investment Management...
...WG Partners did not respond to requests to comment for this article. Table: Woodford investments Woodford Investment Management...
BioCentury | Jan 3, 2020
Financial News

Jan. 3 Financial Quick Takes: Black Diamond plots IPO; plus Oxford Nanopore, CF PharmTech, Mygene and Zerun

...had become available recently. Oxford Nanopore declined to comment on whether funds formerly managed by Woodford Investment Management...
...Li, Staff Writer and Paul Bonanos, Associate Editor Black Diamond Therapeutics Inc. CF PharmTech Inc. Oxford Nanopore Technologies Ltd. Woodford Investment Management Guangzhou...
BioCentury | Oct 19, 2019
Finance

Woodford’s empire crumbles. U.K biotech stays standing

...struggles came to an acrimonious and swift end as the vaunted British investor shuttered the Woodford Investment Management...
...wobbly U.K. sector was still finding its feet (see “Table: Woodford Investments”). Table: Woodford investments Woodford Investment Management...
...believe is in the long-term interests of LF Woodford Equity Income Fund investors.” Neil Woodford, Woodford Investment Management...
BioCentury | Oct 16, 2019
Financial News

Woodford shutters firm, third fund

...grace reached its end Tuesday night when the former star fund manager disclosed his firm, Woodford Investment Management...
...14% in the past three months. “We have taken the highly painful decision to close Woodford Investment Management...
...personally deeply regret the impact events have had on individuals who placed their faith in Woodford Investment Management...
BioCentury | Oct 15, 2019
Financial News

Woodford flagship fund implodes as star fund manager axed

...the repositioning of the fund would be completed. In conjunction with the decision, Link said Woodford Investment Management...
...followed, Woodford participated in some of U.K. biotech’s largest deals. According to BioCentury’s BCIQ database, Woodford Investment Management...
...cash to investors will occur in several intervals thereafter, starting in late January. Stephen Hansen, Associate Editor Woodford Investment Management Woodford...
BioCentury | Oct 8, 2019
Financial News

Woodford fire sale continues with Irish investment firm Malin

...in the Irish investment vehicle to a U.S. fund. The move comes as Neil Woodford’s Woodford Investment Management...
BioCentury | Sep 18, 2019
Financial News

Sept. 18 Financial Quick Takes: IGM gains in first trading day; plus a follow-on roundup, BenevolentAI, UCSF’s InVent Fund and Versantis

...liver disease, is in a first-in-human trial. BC Staff IGM Biosciences Inc. Acadia Pharmaceuticals Inc. Translate Bio Inc. PTC Therapeutics Inc. BenevolentAI Woodford Investment Management Temasek University...
Items per page:
1 - 10 of 117
BioCentury | Jan 11, 2021
Deals

Atopic dermatitis readout drives Sanofi’s $1.1B takeout of Kymab

...Bill & Melinda Gates Foundation and Malin Corp. plc (ISE:MLC) were also shareholders. Funds associated with Woodford Investment Management...
BioCentury | Jun 6, 2020
Finance

Sale of up to 19 Woodford stakes chips away at firm’s remaining portfolio

...unable to meet redemption requests. Subsequent attempts to rebalance the fund failed, and Woodford shuttered Woodford Investment Management...
...years, Woodford participated in some of U.K. biotech’s largest deals. According to BioCentury’s BCIQ database, Woodford Investment Management...
...complete. BlackRock and PJT will continue to seek buyers for the remaining assets. Stephen Hansen, Associate Editor Woodford Investment Management U.K...
BioCentury | Mar 2, 2020
Finance

Immunocore’s $130M series B gives new CEO Jallal capital to progress pipeline

...leadership team. More turmoil followed when one of Immunocore’s largest investors from the series A, Woodford Investment Management...
BioCentury | Feb 10, 2020
Finance

Woodford pain continues as report suggests deal to sell private biotech stakes falls through

...fund. PJT Partners, which is managing the asset sale, declined to comment. Woodford shuttered the Woodford Investment Management...
...WG Partners did not respond to requests to comment for this article. Table: Woodford investments Woodford Investment Management...
BioCentury | Jan 3, 2020
Financial News

Jan. 3 Financial Quick Takes: Black Diamond plots IPO; plus Oxford Nanopore, CF PharmTech, Mygene and Zerun

...had become available recently. Oxford Nanopore declined to comment on whether funds formerly managed by Woodford Investment Management...
...Li, Staff Writer and Paul Bonanos, Associate Editor Black Diamond Therapeutics Inc. CF PharmTech Inc. Oxford Nanopore Technologies Ltd. Woodford Investment Management Guangzhou...
BioCentury | Oct 19, 2019
Finance

Woodford’s empire crumbles. U.K biotech stays standing

...struggles came to an acrimonious and swift end as the vaunted British investor shuttered the Woodford Investment Management...
...wobbly U.K. sector was still finding its feet (see “Table: Woodford Investments”). Table: Woodford investments Woodford Investment Management...
...believe is in the long-term interests of LF Woodford Equity Income Fund investors.” Neil Woodford, Woodford Investment Management...
BioCentury | Oct 16, 2019
Financial News

Woodford shutters firm, third fund

...grace reached its end Tuesday night when the former star fund manager disclosed his firm, Woodford Investment Management...
...14% in the past three months. “We have taken the highly painful decision to close Woodford Investment Management...
...personally deeply regret the impact events have had on individuals who placed their faith in Woodford Investment Management...
BioCentury | Oct 15, 2019
Financial News

Woodford flagship fund implodes as star fund manager axed

...the repositioning of the fund would be completed. In conjunction with the decision, Link said Woodford Investment Management...
...followed, Woodford participated in some of U.K. biotech’s largest deals. According to BioCentury’s BCIQ database, Woodford Investment Management...
...cash to investors will occur in several intervals thereafter, starting in late January. Stephen Hansen, Associate Editor Woodford Investment Management Woodford...
BioCentury | Oct 8, 2019
Financial News

Woodford fire sale continues with Irish investment firm Malin

...in the Irish investment vehicle to a U.S. fund. The move comes as Neil Woodford’s Woodford Investment Management...
BioCentury | Sep 18, 2019
Financial News

Sept. 18 Financial Quick Takes: IGM gains in first trading day; plus a follow-on roundup, BenevolentAI, UCSF’s InVent Fund and Versantis

...liver disease, is in a first-in-human trial. BC Staff IGM Biosciences Inc. Acadia Pharmaceuticals Inc. Translate Bio Inc. PTC Therapeutics Inc. BenevolentAI Woodford Investment Management Temasek University...
Items per page:
1 - 10 of 117